Skip to search formSkip to main contentSkip to account menu

1-n-butylcarbamoyl oxfendazole

Known as: C4-OFZ, Carbamic acid, (1-((butylamino)carbonyl)-5-(phenylsulfinyl)-1H-benzimidazol-2-yl)-, methyl ester 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Benzimidazoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
17-β- (N-ter- butylcarbamoyl) -4-aza -5-alpha-androst-1-en-3-one of the novel polymorphs and methods for their preparation
A 17-β- (N-ter- butylcarbamoyl) -4-aza -5-alpha-androst-1-en-3-novel polymorphs thereof and methods for their preparation A of… 
1991
1991
Antibodies to synthetic platelet-activating factor (1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine) analogues with substituents at the sn-2 position.
We obtained rabbit antibodies by injecting immunogenic conjugates which were prepared by combining covalently 1-O-(15… 
1983
1983
Pharmacokinetic behaviour and anthelmintic efficacy of 1-n-butyl carbamoyl oxfendazole given by intramuscular injection
Oxfendazole (OFZ) was chemically modified to 1-n-butyl carbamoyl OFZ (C4-OFZ) in an attempt to improve the solubility of OFZ and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)